Latest Health News
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
May 08, 2026 20:45 ET | Source: Amplia Therapuetics Limited Melbourne, Australia,…
James Cacioppo Files Updated Early Warning Report
May 08, 2026 16:05 ET | Source: Jushi Holdings Inc. BOCA RATON,…
Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 10, 2026
REGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA(Euronext Brussels/Nasdaq:…
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a…
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF)…
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 07, 2026 19:07 ET | Source: Cue Biopharma, Inc. BOSTON, May…
SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support
Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not…
Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China
BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE:…
